This test helps determine if a person may be less responsive to the drug clopidogrel because of his or her genetic makeup. This test detects genetic variation in the gene CYP2C19. A doctor may sometimes order this test to determine whether clopidogrel will be effective for the person tested or if another drug for treatment may be required.